Skip to content

Clinical research of minimally invasive repair technique based on stem cell in situ activated regeneration strategy in skin and soft tissue injury repair

Clinical research of minimally invasive repair technique based on stem cell in situ activated regeneration strategy in skin and soft tissue injury repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047851
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with skin and soft tissue defects

Interventions

experimental group:Skin soft tissue amplification was used to seal the wound
control group:skin grafts

Sponsors

Shanghai Changhai Hospital Burn Department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. Patients who are diagnosed with skin and soft tissue defects caused by various reasons such as burns, trauma, pressure ulcers and scar resection and need skin grafting or skin flap transfer; 3. The diagnostic criteria for burns refer to the diagnostic criteria of Burn Surgery (Second Edition); 4. The wound or skin and soft tissue defects are located on the limbs or trunk. The width of the wound margin on both sides of the wound on both upper extremities is 3-6cm, and the width of the wound on both sides of the wound on both lower limbs, trunk and buttocks is between 3-10cm. Upright axial) between 3-20cm; 5. The distance between the wound and other wound edges is at least 5cm; 6. There is no obvious infection on the wound surface, and there is no obvious necrotic tissue after thorough debridement; 7. According to GCP regulations, obtain informed consent and voluntarily sign the informed consent form, and volunteer to be tested.

Exclusion criteria

Exclusion criteria: 1. Patients with severe lymphedema, coagulation disorders, autoimmune diseases, cardiovascular and cerebrovascular diseases, severe liver, lung and kidney diseases, and diabetic patients with poor blood sugar control (check HBA1c>8% within one week); 2. The total burn area is greater than 30% TBSA; 3. Severe burns or trauma patients are life-threatening, and the limbs may be at risk of necrosis and amputation; 4. The researchers believe that there are factors affecting wound healing, such as the use of corticosteroids, immunosuppressive drugs and other drugs, and received chemotherapy or radiotherapy within 1 year; 5. Receive or plan to receive drugs or treatments that the investigator believes will interfere with or affect the speed and quality of wound healing; 6. Have participated in or are participating in other clinical investigators within 30 days before screening; 7. Women who are pregnant, pregnant or breastfeeding; 8. Skin and soft tissue augmentation techniques are not suitable for other reasons such as cross-joint sites or poor systemic conditions; 9. Other researchers think that they are not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Mean wound healing time;

Secondary

MeasureTime frame
Total wound closure rate;Wound healing quality;treatment expense;length of stay;

Countries

China

Contacts

Public ContactJi Shizhao

Changhai hospital

shizhaoji@aliyun.com+86 18621583165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026